09/25/2023
6:37 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:54 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
6:37 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
6:38 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
4:31 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/29/2023
4:14 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
4:28 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:10 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:42 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2023
7:32 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:47 PM | FibroGen (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
07/19/2023
6:01 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
7:28 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2023
3:46 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
6:36 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:27 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
8:05 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
8:53 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
5:32 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4/A | |
06/15/2023
7:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:15 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
6:52 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | FibroGen (Issuer)
Lema Gerald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | FibroGen (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | Blaug Suzanne (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:55 PM | Brennan Aoife (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:56 PM | Cravatt Benjamin (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:10 PM | Cravatt Benjamin (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:11 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:14 PM | Blaug Suzanne (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:17 PM | Brennan Aoife (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
6:51 PM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:38 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:10 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:12 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:49 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
06/08/2023
4:51 PM | FibroGen (Subject)
Ho Maykin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:51 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:51 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:31 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:36 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:41 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
9:34 AM | FibroGen (Subject)
Schoeneck James A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:53 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
8:00 AM | FibroGen (Filer)
| Form DEFA14A | |
05/18/2023
6:35 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2023
3:59 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/06/2023
3:32 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2023
4:05 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2023
7:27 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2023
3:50 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4/A | |
03/10/2023
8:53 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2023
8:54 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2023
8:55 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2023
8:55 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2023
8:58 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2023
3:29 PM | FibroGen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/23/2023
7:39 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2023
7:41 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2023
7:42 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2023
7:29 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2023
7:38 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2023
4:26 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 5/A | |
02/08/2023
9:05 AM | FibroGen (Subject)
FIRST TRUST PORTFOLIOS LP (Filed by)
| Form SC 13G/A | |
02/06/2023
11:37 AM | BlackRock Inc. (Filed by)
FibroGen (Subject)
| Form SC 13G/A | |
02/02/2023
4:22 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/10/2023
3:46 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2023
5:35 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4/A | |
01/04/2023
5:33 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4/A | |
12/28/2022
5:38 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2022
4:23 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2022
4:23 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4/A | |
12/14/2022
8:55 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2022
6:19 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2022
6:21 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2022
6:22 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2022
4:41 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2022
3:06 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2022
4:06 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2022
4:30 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
